EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies

Sonila Alia, Gaia Pedriali iD, Paolo Compagnucci iD, Yari Valeri iD, Valentina Membrino, Tiziana Di Crescenzo, Elena Tremoli, Laura Mazzanti, Arianna Vignini iD, Paolo Pinton iD, Michela Casella

Cells · 20.02.2026 · 15 (4) · 372

DOI: 10.3390/cells15040372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 20.02.2026. Verfasst von Sonila Alia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Marche Polytechnic University, 60126 Ancona, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are central regulators of cardiac homeostasis, integrating energy production, redox balance, calcium handling, and innate immune signaling. In cardiovascular disease (CVD), mitochondrial dysfunction acts as a unifying mechanism connecting oxidative stress, metabolic inflexibility, inflammation, and structural remodeling. Disturbances in mitochondrial quality control—encompassing fusion–fission dynamics, PINK1/Parkin- and receptor-mediated mitophagy, biogenesis, and proteostasis—compromise mitochondrial integrity and amplify cardiomyocyte injury. Excess reactive oxygen species, mitochondrial DNA release, and calcium overload further activate cGAS–STING, NLRP3 inflammasomes, and mPTP-driven cell death pathways, perpetuating maladaptive remodeling. Therapeutic strategies targeting mitochondrial dysfunction have rapidly expanded, ranging from mitochondria-targeted antioxidants (such as MitoQ and SS-31), nutraceuticals, metabolic modulators (SGLT2 inhibitors, metformin), and mitophagy or biogenesis activators to innovative approaches including mtDNA editing, nanocarrier-based delivery, and mitochondrial transplantation. These interventions aim to restore organelle structure, improve bioenergetics, and reestablish balanced quality control networks. This review integrates recent mechanistic insights with emerging translational evidence, outlining how mitochondria function as bioenergetic and inflammatory hubs in CVD. By synthesizing established and next-generation therapeutic strategies, it highlights the potential of precision mitochondrial medicine to reshape the future management of cardiovascular disease.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseaseinflammationmitochondrial dysfunctionmitochondrial quality controlmitochondrial signalingmitophagyoxidative stress

Autor:innen und Institutionen

  • Department of Clinical Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
  • GVM Care & Research, Maria Cecilia Hospital, 48033 Cotignola, Italy.
  • Department of Cardiology and Arrhythmology Clinic, Marche University Hospital, 60126 Ancona, Italy.
  • Department of Biomedical Sciences and Public Health, Marche Polytechnic University, 60126 Ancona, Italy.
  • Fondazione Salesi, Ospedale G. Salesi, 60123 Ancona, Italy.
  • Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy.

ORCID-Profile: Gaia Pedriali, Paolo Compagnucci, Yari Valeri, Arianna Vignini, Paolo Pinton

Zitieren

APA

Alia, S., Pedriali, G., Compagnucci, P., Valeri, Y., Membrino, V., Di Crescenzo, T., Tremoli, E., Mazzanti, L., Vignini, A., Pinton, P., & Casella, M. (2026). Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies. Cells, 15(4), 372. https://doi.org/10.3390/cells15040372

Vancouver

Alia S, Pedriali G, Compagnucci P, Valeri Y, Membrino V, Di Crescenzo T, et al. Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies. Cells. 2026;15(4):372. doi:10.3390/cells15040372

BibTeX
@article{Alia2026,
  author = {Alia, Sonila and Pedriali, Gaia and Compagnucci, Paolo and Valeri, Yari and Membrino, Valentina and Di Crescenzo, Tiziana and Tremoli, Elena and Mazzanti, Laura and Vignini, Arianna and Pinton, Paolo and Casella, Michela},
  title = {Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {372},
  doi = {10.3390/cells15040372}
}
Kostenlos starten →